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Induction
Therapeutic angiogenesis has emerged as a promising strategy for the treatment of ischemic diseases such as coronary artery disease and limb ischemia. Transplantation of cultureexpanded endothelial progenitor cells (EPCs) or bone marrow mononuclear cells (BMNCs) showed beneficial effects on left ventricular recovery in patients with myocardial infarction (Napoli et al., 2007) . There is increasing evidence that the initiation of neovascularization in the setting of tissue ischemia is related to the recruitment and activation of monocytes/macrophages within the ischemic tissues (Sanberg et al., 2010; Capoccia et al., 2008) . These monocytes can stimulate endothelial cell proliferation and/or migration through secretion of angiogenic growth factors and proteases (Capoccia et al., 2008; Bouchentouf et al., 2010; Rehman et al., 2003) . It was also proposed that monocytes may differentiate into endothelial cells and get incorporated into the neovasculature (Sharifi et al., 2006; Anghelina et al., 2006) . However, the mechanisms underlying the differentiation of monocytic cells into EC-like cells are still not well defined.
Monocytes are recruited from blood to the damaged tissue by the local production of cytokines and chemokines (Niu et al., 2009; Charo et al., 2004) . The CC chemokine CCL2 (monocyte chemoattractant protein-1, MCP-1) is one of the most frequently observed chemokines following tissue ischemia and has been considered as one of the principal angiogenic factors associated with recruitment of monocytes (Capoccia et al., 2008; Niu et al., 2009; Schwarz et al., 2004) . Administration of exogenous MCP-1 has been shown to increase monocyte/macrophage recruitment, collateral vessel formation, and blood flow to the ischemic tissue in hind limb models of ischemia (Ito et al., 1997; Voskuil et al., 2003) . When monocytes were driven into the heart by cardiomyocyte-targeted expression of MCP-1, the invading monocytes appeared to form erythrocyte-containing vessel-like tunnels (Moldovan et al., 2000) . This article has not been copyedited and formatted. The final version may differ from this version.
JPET Fast Forward. Published on September 5, 2013 as DOI: 10.1124 at ASPET Journals on July 10, 2017 jpet.aspetjournals.org Downloaded from JPET #207316 5 MCP-1 has been shown to mobilize and transdifferentiate bone marrow monocyte lineage cells into EC-like cells (Fujiyama et al., 2003) . We recently discovered that the signaling initiated by MCP-1 binding to its receptor CCR2 in human peripheral blood monocytes triggered the induction of a novel CCCH-type zinc-finger protein, named MCP-1-induced protein (MCPIP, also known as Zc3h12a or Regnase-1) (Zhou et al., 2006) . MCPIP is a cytoplasmic protein expressed primarily in immune cells and can be induced in multiple cell types by many proinflammatory agents such as interleukin-1β (IL-1β), tumor necrosis factor α , bacterial lipopolysaccharide, and phorbol 12-myristate-13-acetate (Jura et al., 2008; Liang et al., 2008) .
Up to date reports suggest that MCPIP is a key factor controlling the inflammatory state as well as apoptosis and differentiation (Matsushita et al., 2009; Vrotsos et al., 2009; Younce et al., 2009; Liang et al., 2011; Takuya et al., 2013) . Furthermore, overexpression of MCPIP in human umbilical vein endothelial cells (HUVECs) showed angiogenic activity by induction of cadherin (cdh)-12, -19 (Niu et al., 2008) and involvement of endoplasmic reticulum (ER) stress and autophagy (Roy et al., 2012) . Because MCP-1 is one of the principal angiogenic factors associated with recruitment of monocytes (Capoccia et al., 2008) 
Materials and Methods
This article has not been copyedited and formatted. The final version may differ from this version. Human BMNCs purchased from Stemcell Technologies were cultured in endothelial cell basal medium (EBM) supplemented with hydrocortisone (1μg/ml), bovine brain extract (12μg/ml), gentamicin (50μg/ml), amphotericin B (50ng/ml), epidermal growth factor (10ng/ml), and 2% fetal bovine serum (Clonetics) at 37°C in a humidified 5% CO 2 incubator. To examine whether MCP-1-induced differentiation of BMCs into ECs is mediated via MCPIP, BMCs were incubated in EBM medium with the presence or absence of 100 nm of MCPIP siRNA as described previously (Niu et al., 2008) . Then 100 ng/ml of the recombinant human MCP-1 were added to the medium for 48 h. Gene expression changes for cell markers Tie-2 and CD11b were assayed by RT-PCR, qRT-PCR as described below. Experiments were repeated at least three times to provide their reproducibility.
Cell Transfection.
BMNCs were seeded at 2 × 10 5 cells per well in six-well plates and cultured in the complete EBM medium for 3 days. After removal of the non-adherent cells, the attached cells were transfected with 1μg of pEGFP/N1 vector or 1μg of pEGFP-MCPIP plasmid for 24 h as previously described (Zhou et al., 2006; Niu et al., 2008) . The attached cells were continually cultured in the complete EBM medium for 7 days, and then harvested for gene expression analysis. For gene silence studies, the attached cells were pre-incubated with Opti-MEM® I medium containing FuGENE 6/siRNA mixture (final concentration 100nM of siRNA) for 6 h before any treatments. siRNA for MCPIP, cdh12, and cdh19 was designed by Dharmacon (Lafayette, CO) as described previously (Niu et al., 2008) . siRNA for Beclin-1 was purchased from Santa Cruz Biotechnology. For inhibitor intervention experiments, the attached cells were pre-incubated with 100µM of tauroursodeoxycholate (TUDC, Sigma-Aldrich) or 50µM of 3'-This article has not been copyedited and formatted. The final version may differ from this version.
JPET Fast Forward. Published on September 5, 2013 as DOI: 10.1124 at ASPET Journals on July 10, 2017 jpet.aspetjournals.org Downloaded from JPET #207316 7 methyladenine (3'-MA, Sigma-Aldrich) in the complete EBM medium for 6 h before gene transfection. Experiments were repeated at least three times to provide their reproducibility.
Reverse Transcription-Polymerase Chain Reaction (RT-PCR) Analysis.
Total RNA from cultured cells or tissues of mice was prepared and reverse transcribed into cDNA and subjected to semi-quantitative RT-PCR with the primers as described previously (Niu et al., 2008) products were electrophoresed on agarose gel and RNA expression levels were normalized to β -actin as previously described (Niu et al., 2008) .
Real-time Quantitative RT-PCR (qRT-PCR).
qRT-PCR was performed on iCycler Real-Time PCR system (Bio-Rad) using SYBR Green Premix Kit (Applied Biosystems) with the primers as described previously (Niu et al., 2008) 
Western Blotting.
Lysates from cultured cells or tissues of mice were prepared as described previously (Niu et al., 2008; . The lysates were then subjected to SDS-PAGE and transferred onto nitrocellulose membranes. Immunoblot analysis was completed as described previously (Niu et al., 2008; . Primary rabbit polyclonal antibodies were as follows: human MCPIP, 1:500; Flk-1, 1:1000; Tie-2, 1:500; CD31, 1:500; cdh-12, 1:500 (R&D Systems); and VEGF, 1:1000; cdh-19, 1:1000 (Abnova). The specific bands were quantified using a densitometer equipped with an imaging system (Alpha imager 2200).
Immunofluorescence Staining and Uptake of Dil-acLDL.
BMNCs cells were seeded at 5×10 5 /ml in Lab-Tek chamber glass slides (Nalge Nunc
International, Rochester, NY) and transfected with MCPIP expression or control vector. After culture for 7 days, cells were fixed and permeabilized in 4% paraformaldehyde in PBS with 0.1% Triton X-100 for 10 min at room temperature. After blocking with 3% bovine serum albumin, cells were incubated with MCPIP, CD31 and CD144 antibodies, respectively, overnight at 4°C.
Cells were then incubated with Cy3-or FITC-conjugated secondary antibodies (Invitrogen) for 2 hours at room temperature and nuclei were counterstained with DAPI and prepared for fluorescence microscopy. Lipoproteins labeled with the fluorescent probe 1,1'-dioctadecyl-3,3,3',3'-tetramethyl-indocarbocyanine perchlorate (DiI-acLDL) have been utilized to visualize the uptake of lipoproteins by endothelial cells (Voyta et al., 1984; Gaffney et al., 1985) . For DilacLDL uptake analysis, at days 7 after transfection, cells were incubated with 2.5µg/ml DilThis article has not been copyedited and formatted. The final version may differ from this version. In Vitro Matrigel Analysis.
Matrigel was prepared as previously described (Niu et al., 2008) . by excising the proximal regions of the femoral and saphenous arteries. The wound was closed and animals were brought back to the cages with free access to food and water. At 24 hours after surgery, animals (n=5 per group) were injected intravenously via tail vein with 100µl of EBM medium loaded with BMNCs (5×10 5 /ml) transfected with MCPIP expression vector or control vector. On days 3 and 28 after cell transplantation, the adductor muscles were collected, and fixed in 10% phosphate-buffered formaldehyde or snap-frozen in liquid nitrogen. The fixed tissues were routinely processed and sliced into 5 µm sections for hematoxylin and eosin staining.
Capillary-like structures were calculated and averaged from five randomly selected high power fields (HPF, 400-fold). Immunohistochemistry was performed to determine CD31 expression in situ with Alexa Fluor 594-labled anti-mouse CD31 antibody. Photomicrographs were obtained under ×400 magnification.
Statistical Analysis.
Data are expressed as the mean ± S.D. of a given number of observations. Results were compared between groups by Student's t tests using SPSS 10.0 software (SPSS Inc.) under Windows XP. A p value of <0.05 was considered to be significant.
Results
Knockdown of MCPIP inhibited the MCP-1-induced differentiation of BMNCs into ECs.
Bone marrow monocyte lineage cells have been shown to promote reendothelialization in a JPET #207316
11 assessed by analysis of the expression of CD11b, a cell-surface marker of differentiated monocytic cells (Alessio M, et al., 1996; Kamiya et al., 2011) , and Tie-2, a surface marker of differentiated ECs (Sharifi et al., 2006; Kim et al., 2009) . MCP-1 treatment of BMNCs resulted in up-regulation of Tie-2 and down-regulation of CD11b (Fig.1, A and B), suggesting transdifferentiation of BMMCs into ECs. Pretreatment with siRNA against MCPIP significantly inhibited MCP-1-induced upregulation of Tie-2 and downregulation of CD11b (Fig.1, A and B) .
Moreover, MCP-1-induced formation of cobblestone-like morphology and uptake of Dil-acLDL, a widely used marker for assay of endothelial function (Voyta et al., 1984; Gaffney et al., 1985) , a spindle shape and the remaining cells were retained their rounded shape (Fig. 2E) . Furthermore, when cells were cultured in the EndoCult Liquid Medium for 5 days, we observed an increase in numbers of EC-colony in BMNCs transfected with MCPIP when compared to BMNCs transfected with GFP control (Fig.2, F and H) . These morphological changes indicated that expression of MCPIP in BMNCs promoted differentiation of BMNCs into endothelial-like cells.
Forced Expression of MCPIP Induces Transdifferentiation of BMNCs into Functional ECs.
We further examined the expression changes of cell surface markers in BMNCs at day 7 after transfection with MCPIP expression vector. RT-PCR analysis showed that expression of MCPIP induced upregulation of EC specific markers, flt-1, flk-1, Tie-2, and CD31, and downregulation of monocytic specific markers, CD14 and CD11b, when compared to that of the GFP-transfected BMNCs (Fig.3 , A to C). We also immunocytochemically examined the expression of CD31 and CD144 (VE-cadherin), two specific EC-surface markers, in BMCs transfected with Flag-tagged MCPIP or Flag-tagged empty vector. At day 7 after transfection, much larger percentage of BMNCs showed an intense cytoplasmic fluorescence for CD31 and CD144 in MCPIPtransfected BMNCs, when compared to BMNCs transfected with control vector (Fig.3, D 
and E).
Uptake of acLDL is a feature of endothelial cells and has been utilized for assay of endothelial cell function (Voyta et al., 1984; Gaffney J et al., 1985) . We performed the DilacLDL uptake assay on BMNCs 7 days after transfection with MCPIP expression vector. A much larger proportion of the BMNCs transfected with MCPIP were positive for Dil-acLDL when compared to Flag-tagged empty vector (Fig.3, F 13 tagged MCPIP expression vector or control vector for 7 days, BMNCs were labeled with DilacLDL and were co-cultured with HUVECs in EBM medium on Matrigel for 24 h. We observed incorporation of Dil-acLDL-labeled cells into vascular networks (Fig. 3H, arrows) , and cells transfected with MCPIP showed enhanced incorporation in comparison with the empty vector transfected cells (Fig. 3I) , suggesting that expression of MCPIP in BMNCs promoted differentiation of BMNCs into functional endothelial cells.
Signaling Pathways of MCPIP-mediated Endothelium-like Differentiation of BMNCs.
ER stress and autophagy have been implicated in MCPIP-mediated differentiation processes (Wang et al., 2011; Younce et al., 2012; Roy et al., 2012) . To test whether such processes are involved in the transdifferentiation of BMNCs to ECs, we examined the expression of Grp78, an ER stress marker, and Beclin-1, an autophagy marker, in MCPIP-transfected BMNCs. These ER stress and autophagy markers were induced in the BMNCs transfected with MCPIP expression vector (Fig. 4A) . Furthermore, when cells were treated with TUDC, a specific inhibitor of ER stress (Ozcan et al., 2006) , MCPIP-induced upregulation of Tie-2, Flk-1, and VEGF was significantly inhibited at both mRNA and protein levels (Fig.4, B to D) . Similarly, inhibition of autophagy by knockdown of Beclin-1 with siRNA inhibited MCPIP-mediated induction of Tie-2
and Flk-1 in BMCs (Fig.4 , E to G). Treatment of BMNCs with 3-MA, a widely used inhibitor of autophagy (Seglen et al., 1982; Kovacs, et al., 1998) , also led to a significant inhibition of MCPIP-induced expression of Tie-2 and Flk-1 in BMNCs (Fig.4, H Luo et al., 2005) . We tested whether cdh12 and cdh19, two target genes of MCPIP (Niu et al., 2008) , might be involved in MCPIP-mediated attachment by BMNCs. Real-time PCR analysis showed that expression of cdh12 and cdh19 were induced in BMNCs after transfection with MCPIP-GFP expression vector compared with cells transfected with the GFP control (Fig.   5A ). Furthermore, knockdown of cdh 12 or cdh19 with siRNA specific for either cdh12 or cdh19
significantly reduced MCPIP-induced enhancement of BMNCs attachment (Fig. 5B) . Specificity of knockdown for cdh12 or cdh19 was indicated by the real-time PCR and immunoblot analysis
showing that MCPIP-induced expression of cdh12 or cdh19 at both transcript and protein levels were markedly suppressed by treatment with siRNA for either cdh12 or cdh19 but not nonspecific siRNA (Fig.5 , C to E). Importantly, we observed that siRNA for cdh12 or cdh19 markedly suppressed MCPIP-induced upregulation of Tie-2 and Flk-1 (Fig.5, F and G),
suggesting that induction of cdh12 and cdh19 is involved in MCPIP-mediated endothelial differentiation in BMNCs.
MCPIP-modified BMNCs Contribute to Tissue Vascularization in Ischemic Limbs.
Finally, we evaluated whether transplantation of MCPIP-transfected BMNCs systemically would enhance ischemic neovascularization in mice limbs. Expression of CD31 in the ischemic tissues at days 3 and 28 after transplantation were examined by RT-PCR and immunoblot analysis. A significant increase in CD31 expression in ischemic tissues was found in mice transplanted with MCPIP-transfected BMNCs compared to mice that were transplanted with empty vectortransfected BMCs (Fig.6, A to D) . In histological analysis, we observed CD31-positive cells in the ischemic limb at days 28 after cell transplantation, and the number of CD31-positive cells in the ischemic zone was significantly higher in mice that received MCPIP-transfected BMNCs compared to mice transplanted with empty vector-transfected BMNCs (Fig. 6E ). An increase in This article has not been copyedited and formatted. The final version may differ from this version. (Capoccia et al., 2008; Moldovan et al., 2000; Fujiyama et al., 2003; Schwarz et al., 2004) . The invading monocytes within the ischemic myocardium have been shown to form erythrocyte-containing vessel-like tunnels (Moldovan et al, 2000) . Recently, these results have been supported by in vivo findings showing BMNCs adhere on injured endothelium and accelerate reendothelialization in a MCP-1-dependent manner (Fujiyama et al., 2003) . MCPIP was originally discovered as a protein induced by MCP-1 in human peripheral blood monocytes and is expressed in mononuclear cells in the highly vascularized zones of ischemic myocardium (Zhou et al., 2006) . myeloid angiogenic cells to enhance ischemic neovascularization in models of myocardial infarction and hind limb ischemia (Kawamoto et al., 2001; Urbich et al., 2003) . It is likely that these MCPIP-modified BMNCs from the circulation reached the ischemic area and served as a source for EPCs required for neovascularization. It is also possible that MCPIP-modified BMNCs may act as supporting cells during vascular repair by the release of proangiogenic factors. Indeed, monocytes/macrophages have been shown to compensate for neovascularization by drilling of metalloelastase-positive tunnels in ischemic myocardium (Moldovan et al., 2000) .
Adult bone marrow contains only a small subpopulation of EPCs that can proliferate and differentiate into mature endothelial cells. We demonstrated that forced expression of MCPIP in
BMNCs enhances the ability of BMNCs to function as EPCs for neovascularization in ischemic tissue. This finding not only provides an efficient approach to achieve the functional EPCs from
BMNCs but also has potential clinical application for therapeutic angiogenesis in ischemic diseases.
Enhancement of transdifferentiation of BMNCs into ECs by MCPIP was, at least in part,
mediated by the induction of its target genes cdh12 and cdh19, both of which belong to Ncadherin family which is a transmembrane glycoprotein that mediates cell-matrix adhesion (Blaschuk et al., 2000; Luo et al., 2005) . Both cdh12 and cdh19 have been shown to be transcriptionally activated by MCPIP (Niu et al., 2008) . Cell differentiation involves the significant expansion of the ER, resulting ER stress to support the elevated production of a new set of proteins (Wiest et al., 1990; Franco et al., 2010; Oh et al., 2012) . Differentiation also involves disappearance of one set of proteins by a selfdigestion process such as autophagy, which has been demonstrated to be involved in differentiation in several contexts (Aymard et al., 2011; Salemi et al., 2012) . Tie-2 and Flk-1. This observation suggests that both ER stress and autophagy are involved in endothelial cell transdifferentiation process. In agreement with these findings, transgenic expression of MCP-1 triggers ER stress in the heart (Azfer et al., 2006) and the invading monocytes in the heart appeared to form erythrocyte-containing vascular-like tunnels (Moldovan et al., 2000) , suggesting that ER stress may be an important angiogenesis promoter in MCP-1-induced vascular-like tunnel formation in vivo. ER stress was recently reported to promote angiogenesis by activation of VEGF transcription (Pereira et al., 2010) . Autophagy has been also reported to be an important angiogenesis enhancer, as inhibition of autophagy by 3-MA or knockdown of ATG5 inhibits tube-like structure formation in bovine aortic endothelial cells ( 
